about
A Protocol for the secure linking of registries for HPV surveillanceHPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinomaCharacteristics and survival of head and neck cancer by HPV status: a cancer registry-based study.Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa RicaTrends in Genital Warts in the Era of Human Papillomavirus Vaccination.Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global reviewT-cell epitope vaccine design by immunoinformatics.Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico.A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.Dual roles for immunity in gastrointestinal cancers.Strategies for continuous evaluation of the benefit-risk profile of HPV-16/18-AS04-adjuvanted vaccine.Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis.Re: Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study.Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010Nonlinear Pulse Vaccination in an SIR Epidemic Model with Resource Limitation
P2860
Q28727618-C21471F1-EDDE-4FB5-9ACA-392F7AEE1FFEQ28730863-FC3D815F-F8E3-4731-939B-C2297FA04812Q34011808-EC7F5434-4796-4D6D-A224-E15FB8ED2D69Q34764776-5643EDEF-E83E-466F-BB3E-0ACB61357E9FQ35870672-DBCCC9EF-ADBF-4E0D-87FB-3F92F70E793BQ35967430-E9B41054-40A3-4C08-BE21-929B0426B6EDQ36289231-A86709F3-C074-4318-AB66-4AA45576E0ACQ36609068-6544AAD6-58CA-4025-A679-F6567E9E553AQ36702419-E9409D7E-EE74-4E78-957D-1BDCD179E2A1Q37224673-E87694D9-B092-4B95-B612-B6DE51A6D340Q37366649-7533406F-C8F2-4537-9DDA-1A378D196C3FQ37774172-A2FB214E-CFD0-4F53-9370-9F7B83FD7499Q38248947-BA7CBE73-D83E-4223-9C40-85B2BF2F393DQ39250694-6CC22FBB-CA84-4D52-B00D-CB77059E4063Q42544236-5BF972BF-9ADD-472E-A3F0-639196345D45Q45215935-D6605FF3-F3FF-4940-A52E-7AA72B8DD8C6Q56895750-CE6C9482-104F-486E-909C-3C13EC7E78F0Q58916549-2A5587E3-1A99-4209-910A-0F80822227F1
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evaluating the impact of human papillomavirus vaccines.
@ast
Evaluating the impact of human papillomavirus vaccines.
@en
Evaluating the impact of human papillomavirus vaccines.
@nl
type
label
Evaluating the impact of human papillomavirus vaccines.
@ast
Evaluating the impact of human papillomavirus vaccines.
@en
Evaluating the impact of human papillomavirus vaccines.
@nl
prefLabel
Evaluating the impact of human papillomavirus vaccines.
@ast
Evaluating the impact of human papillomavirus vaccines.
@en
Evaluating the impact of human papillomavirus vaccines.
@nl
P2093
P1433
P1476
Evaluating the impact of human papillomavirus vaccines.
@en
P2093
Allen C Rinas
Jennifer S Smith
Karla Schmitt
Noel T Brewer
Yuli Chang
P304
P356
10.1016/J.VACCINE.2009.03.008
P407
P577
2009-03-13T00:00:00Z